Lung cancer is still one of the most common and deadly cancer worldwide, which is why Worldwide Cancer Research has already funded over £6 million into ground-breaking lung cancer research. This year alone, we have seen ten amazing new breakthroughs from researchers across nine countries, investigating innovative new ways to better understand, and ultimately stop lung cancer.
When Dad was diagnosed with advanced small-cell lung cancer, we were told he might have six months, maybe a year, to live with treatment. Thanks to advances in cancer research and treatment, we were fortunate enough to have another six years with him.
How common is lung cancer?
Sadly, lung cancer still affects a huge number of people every single year.
It caused 1.8 million deaths worldwide in 2024; the single largest number of deaths for any cancer. There are many different reasons why we urgently need more research for lung cancer, and multiple types of lung cancer that can act and respond to treatment differently. Mesothelioma, for example, is a cancer commonly grouped with lung cancers as it begins in the tissue lining the lungs and presents similarly.
The research we have already funded has brought new improvements and understanding to lung cancer treatment, but we still need more. With your support, amazing projects like these are taking crucial steps forward towards a day when no life is cut short by lung cancer.
How can we make lung cancer treatment more effective for all lung cancer patients?
Just like every person's experience of cancer is different, every individual cancer is different, so we cannot treat them with a one-size-fits-all approach.
Through their recent breakthrough in understanding the behaviours of different subtypes of lung cancer, Dr Lynette Fernandez-Cuesta and her team in France are hopeful they could improve patient diagnosis and treatment through matching patients to process that work best for their cancer specifically.
Professor Peter Carmeliet and his team in Belgium, meanwhile, have figured out a way to test how cancers become resistant to immunotherapy.
How can we develop targeted drugs for mesothelioma?
Dr Carsten Hansen and his team in Scotland have been investigating a chain reaction that happens in mesothelioma cells that causes them to grow.
The process is like a domino effect, with each domino in the row causing the next to fall until the last hits an 'on-switch'. Excitingly, through tireless detective work, they have figured out how each step in this row of dominoes works.
The team now hope to target part of this process, essentially taking a crucial domino out of the row to interrupt the growth and stop mesothelioma in its tracks.
How can we unlock new personalised treatments for lung cancer?
Until now, we haven’t been able to understand why two different patients with the exact same cancer can have completely different responses to a therapy.
Amazingly, Professor Rocio Sotillo and her team in Germany have made a breakthrough, figuring out that tiny variations in the same cancer-causing gene can change how the cancer behaves and how effective treatment is.
Now they think they could predict which treatments are most likely to work for which patients. This would offer patients more accurate and effective treatments and care, that works best for them and their cancer.
Our work shows that the exact form of this faulty gene shapes how a tumour grows. This brings us closer to choosing the right treatment for each patient. Thank you to every supporter who made this possible.
How can we stop lung cancer from spreading?
Thanks to supporters like you, we funded Dr Inbal Wortzel and her team in the USA to investigate little packages of DNA called exosomes that can move through the blood stream to help cancer cells spread.
Her most recent breakthrough uncovers molecular details that they think they can use to interrupt cancer spread in lung and colorectal cancer patients. It is all linked to how these little packages of DNA communicate with blood vessels to make them ‘leaky’.
We know that understanding how cancer spreads and how to stop metastasis is crucial to help more patients - seeing the progress that Dr Wortzel and her team are making in this research gives us real hope for the future.
How can ground-breaking new tools accelerate the pace of lung cancer research?
International cancer research thrives on the collaboration between lots of talented specialists working together. When researchers publish tools like this, discoveries can be accelerated and, ultimately, cures can get to patients faster.
How can discovery research breakthroughs have a wider impact?
Your donations support research into all types of cancer but two exciting lung cancer projects that we funded are now having an incredible impact across other diseases too.
We funded Professor Stefano Angiari, based in Austria and Professor Karibaan Hodivala-Dilke in England, to study our immune system. While both of their projects are making considerable strides in lung cancer research, Professor Angiari has also made a discovery that could be crucial for treating autoimmune diseases such as multiple sclerosis, while Professor Hodilva-Dilke is uncovering how some breast cancers can become resistant to chemotherapy.
We look forward to seeing how their research continues to unfold and what their breakthroughs could mean for patients.
I support charities like Worldwide Cancer Research because I know first-hand how much of difference cancer research can make. I want other families to have the chance of more time together, just as we did with Dad.
Join our united effort to stop cancer.
There are so many different ways to support our search for new cures. Will you join the 90,000+ Curestarters who are already helping us get closer to a day when no life is cut short by cancer?